The successful synthesis of X-2 immune enhancer proves that Yang Ping's approach is correct. Previously, vaccines could only use adjuvants to enhance immune effects. Now, Yang Ping has provided a new idea, utilizing genetic recombination technology to embed a specific protein structure into vaccines. This protein structure can enhance the vaccine's immune effect.
X-2 is the first such protein molecule, featuring high versatility that can be embedded in various vaccines. Moreover, it enhances immunity without increasing the vaccine's toxicity and side effects.
Although the project has only achieved preliminary results and has multiple phases of clinical trials ahead, this already marks the failure of those multinational giants' blockade. Yang Ping can completely detach from their technical systems and leverage existing domestic equipment and technology to complete drug development.
